Loading asset research
Curanex Pharmaceuticals Inc Common Stock
CURXNasdaq · USD · StocksQuote as of · Exchange session not verified$4.55
+5.57%
Today
CURX
Loading 1D prices…
Market cap
$7.1M
Volume
7.4K
52w high
$9.1852w low
$0.205Company profile
Curanex Pharmaceuticals Inc Common Stock
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Jericho, NY, United States
Employees
6
Fiscal year end
1231
CIK
2025942
Session & valuation
Open$4.34
Previous close$4.31
Day high$4.55
Day low$4.33
30-day avg. volume39.8K
Outstanding shares31.4M
Diluted EPS-$0.17
Latest annual period
P/E (trailing)-26.76
P/E (forward)—
Price / book1.35
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| INMInMed Pharmaceuticals Inc. Common Shares | $7.1M | $0.00 | — | -$3.12 | -1.53% | Unrated |
| GELSGelteq Limited Ordinary Shares | $7.5M | — | — | -$0.72 | -5.96% | Unrated |
| BOLTBolt Biotherapeutics Inc. Common Stock | $7.6M | $7.7M | -433.74% | -$17.85 | +5.90% | Hold |
| SNGXSoligenix Inc. Common Stock | $7.9M | $0.00 | — | -$2.14 | 0.00% | Unrated |
| ENVBEnveric Biosciences Inc. Common Stock | $6.4M | $0.00 | — | -$36.24 | -1.37% | Unrated |